Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07443293) titled 'IMPACT 360 for Parkinson's Disease' on Feb. 24.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of British Columbia
Condition:
Parkinson's Disease (PD)
REM Sleep Behavior Disorder
Intervention:
Behavioral: Exercise
Behavioral: Meditation
Recruitment Status: Recruiting
Phase: Phase 2
Date of First Enrollment: October 28, 2024
Target Sample Size: 60
Countries of Recruitment:
Canada
To know more, visit https://clinicaltrials.gov/study/NCT07443293
Published by HT...